REGN
Regeneron Pharmaceuticals, Inc. · Healthcare
Director N Anthony Coles sold $3.9M of Regeneron Pharmaceuticals, Inc.
Sold$3,900,000
$650.00Price
6,000Shares
−87%Stake
What REGN did after the filing
- The stock from Thu, Aug 19 close, $650.26
- −12.9%
- S&P 500, same days
- −1.0%
Measured over 30 trading days, to the Oct 1 close.
Traded Tue, Aug 17. Filed Thu, Aug 19, 12:04 PM ET, during the session. Returns use the Aug 19 close and the Oct 1 close. Not investment advice.